Sponsored Content

As the monoclonal-antibody (mAb) market continues to grow, it is becoming increasingly important for pharmaceutical and biotech companies to accelerate process development and establish a scalable manufacturing process capable of achieving high titers and consistent product quality. Central to this is a cell culture media and feed system that can provide the required nutrients for optimal cell growth, viability, and function, as well as facilitate a seamless transition from development to clinical and commercial manufacturing. However, choosing an appropriate system can be a complex and time-consuming process, often requiring the evaluation of multiple medium and feed options. Platform systems, consisting of a medium and complementary feed developed for a specific cell line and application, have emerged as a valuable option for developers to help simplify selection and increase scale-up efficiency. To meet the need for high-performance platform mAb manufacturing solutions, Thermo Fisher Scientific has dev...

Sponsored Content

This webcast features: Roland Pach, PhD, Global Analytical Expert, CMC, CGT, & Alternative Formats, Roche. Gene therapy based therapeutics offer revolutionary ways of treating and curing genetic disorders. CMC plays a crucial part, however it is faced with complex manufacturing processes and the intrinsic complexity of the genetic therapeutics themselves. In this webinar, learn about key pre-quality attributes in AAV manufacturing and the cognate landscape of technologies analyzing them. There is a high need for more sophisticated methods for improving and deepening the understanding of the process and product. Key Takeaways: Register or Login and hit Watch on Demand to view the recorded webcast now.